TWO SIGMA INVESTMENTS, LP

Position in IFRX — InflaRx N.V.

CIK 1179392 NEW YORK, NY

Position in IFRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$405,704

+$236,671 QoQ

Shares Held

181,118

-4.2% QoQ

Ownership

0.123%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 62 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

TWO SIGMA INVESTMENTS, LP holds $7,283,390,440 across 343 Biotechnology names. IFRX ranks #260 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	1,875,937	$564,713,315
2	MRNA	Moderna, Inc.	7,193,530	$503,762,905
3	IONS	Ionis Pharmaceuticals Inc	6,252,342	$495,748,197
4	REGN	Regeneron Pharmaceuticals, Inc.	656,124	$409,119,558
5	BBIO	BridgeBio Pharma, Inc.	4,722,185	$351,708,338
6	EXEL	Exelixis, Inc.	4,209,861	$229,058,537
7	INCY	Incyte Corp	2,003,559	$227,123,448
8	ARGX	Argenx SE	185,638	$172,229,367

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$405,704	181,118	-4.2%	Shares	Sole	2026-08-14
2026-03-31	$169,033	189,075	-53.5%	Shares	Sole	2026-05-15
2025-12-31	$410,378	406,315	+1960.8%	Shares	Sole	2026-02-17
2024-12-31	$48,698	19,716	-17.9%	Shares	Sole	2025-02-14
2024-09-30	$36,739	24,013	-53.4%	Shares	Sole	2024-11-14
2024-06-30	$89,681	51,541	-49.6%	Shares	Sole	2024-08-14
2024-03-31	$157,411	102,215	-26.1%	Shares	Sole	2024-05-15
2023-12-31	$225,551	138,375	+1013.7%	Shares	Sole	2024-02-14
2023-09-30	$37,026	12,425	-74.8%	Shares	Sole	2023-11-14
2022-03-31	$90,083	49,226	-18.2%	Shares	Sole	2022-05-16
2021-12-31	$286,404	60,169	+443.5%	Shares	Sole	2022-02-14
2021-09-30	$28,671	11,070	-83.4%	Shares	Sole	2021-11-15
2020-06-30	$305,859	66,636	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.